These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 9892010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation.
    Sellers LA, Feniuk W, Humphrey PP, Lauder H.
    J Biol Chem; 1999 Jun 04; 274(23):16423-30. PubMed ID: 10347203
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S, Pattarozzi A, Massa A, Esteve JP, Iuliano R, Fusco A, Susini C, Florio T.
    Mol Endocrinol; 2007 Jan 04; 21(1):229-46. PubMed ID: 17021051
    [Abstract] [Full Text] [Related]

  • 8. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.
    Florio T, Rim C, Hershberger RE, Loda M, Stork PJ.
    Mol Endocrinol; 1994 Oct 04; 8(10):1289-97. PubMed ID: 7854346
    [Abstract] [Full Text] [Related]

  • 9. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR, Oo ML, Senga T, Suzuki N, Feng GS, Hamaguchi M.
    Cancer Res; 2003 Oct 01; 63(19):6334-9. PubMed ID: 14559821
    [Abstract] [Full Text] [Related]

  • 10. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
    Guillemot L, Levy A, Zhao ZJ, Bereziat G, Rothhut B.
    J Biol Chem; 2000 Aug 25; 275(34):26349-58. PubMed ID: 10843991
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C.
    Biochem J; 1997 Jul 15; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
    Takeda H, Matozaki T, Fujioka Y, Takada T, Noguchi T, Yamao T, Tsuda M, Ochi F, Fukunaga K, Narumiya S, Yamamoto T, Kasuga M.
    Oncogene; 1998 Jun 11; 16(23):3019-27. PubMed ID: 9662335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.
    Wylie PG, Challiss RA, Blank JL.
    Biochem J; 1999 Mar 15; 338 ( Pt 3)(Pt 3):619-28. PubMed ID: 10051431
    [Abstract] [Full Text] [Related]

  • 16. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1.
    Pagès P, Benali N, Saint-Laurent N, Estève JP, Schally AV, Tkaczuk J, Vaysse N, Susini C, Buscail L.
    J Biol Chem; 1999 May 21; 274(21):15186-93. PubMed ID: 10329727
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N, Calvo E, Coulombe Z, Muradia G, Bastien J, Aubin RA, Lajas A, Morisset J.
    Endocrinology; 1999 Feb 21; 140(2):765-77. PubMed ID: 9927304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A, Tartaglia M, Wu J, Gelb BD.
    Hum Mutat; 2004 Mar 21; 23(3):267-77. PubMed ID: 14974085
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.